Latest period
$8.60B
YoY change
-22.1%
5Y CAGR
-3.9%
Peak year (2018)
$10.56B
Latest annual
$8.10B
Free Cash Flow history chart for Amgen (AMGN) from 1988 to 2025
Latest: $8.10B
Free Cash Flow growth chart for Amgen (AMGN) from 1988 to 2025
Latest: -22.1%
Free Cash Flow history table for Amgen (AMGN) from 1988 to 2025
| 2025 | $8.10B | -22.1% | −$2.29B | ||
| 2024 | $10.39B | +41.2% | +$3.04B | ||
| 2023 | $7.36B | -16.2% | −$1.43B | ||
| 2022 | $8.79B | +4.8% | +$404.00M | ||
| 2021 | $8.38B | -15.2% | −$1.51B | ||
| 2020 | $9.89B | +15.9% | +$1.36B | ||
| 2019 | $8.53B | -19.2% | −$2.03B | ||
| 2018 | $10.56B | +0.4% | +$45.00M | ||
| 2017 | $10.51B | +10.5% | +$996.00M | ||
| 2016 | $9.52B | +12.9% | +$1.09B | ||
| 2015 | $8.43B | +11.6% | +$876.00M | ||
| 2014 | $7.55B | +34.9% | +$1.95B | ||
| 2013 | $5.60B | +7.8% | +$405.00M | ||
| 2012 | $5.19B | +14.1% | +$641.00M | ||
| 2011 | $4.55B | -12.6% | −$655.00M | ||
| 2010 | $5.21B | -10.3% | −$599.00M | ||
| 2009 | $5.81B | +9.2% | +$490.00M | ||
| 2008 | $5.32B | +28.6% | +$1.18B | ||
| 2007 | $4.13B | -0.9% | −$37.00M | ||
| 2006 | $4.17B | +3.1% | +$127.00M | ||
| 2005 | $4.04B | +71.3% | +$1.68B | ||
| 2004 | $2.36B | +6.8% | +$151.20M | ||
| 2003 | $2.21B | +39.0% | +$619.50M | ||
| 2002 | $1.59B | +53.1% | +$551.90M | ||
| 2001 | $1.04B | -13.2% | −$158.50M | ||
| 2000 | $1.20B | +55.2% | +$425.80M | ||
| 1999 | $771.10M | +21.7% | +$137.40M | ||
| 1998 | $633.70M | +23.0% | +$118.60M | ||
| 1997 | $515.10M | -7.3% | −$40.60M | ||
| 1996 | $555.70M | -9.0% | −$54.80M | ||
| 1995 | $610.50M | +52.2% | +$209.40M | ||
| 1994 | $401.10M | +79.8% | +$178.00M | ||
| 1993 | $223.10M | +205.6% | +$150.10M | ||
| 1992 | $73.00M | -28.7% | −$29.40M | ||
| 1991 | $102.40M | -299.2% | +$153.80M | ||
| 1990 | −$51.40M | +102.4% | −$26.00M | ||
| 1989 | −$25.40M | -48.3% | +$23.70M | ||
| 1988 | −$49.10M | — | — |
- 2025$8.10B-22.1%
- 2024$10.39B+41.2%
- 2023$7.36B-16.2%
- 2022$8.79B+4.8%
- 2021$8.38B-15.2%
- 2020$9.89B+15.9%
- 2019$8.53B-19.2%
- 2018$10.56B+0.4%
- 2017$10.51B+10.5%
- 2016$9.52B+12.9%
- 2015$8.43B+11.6%
- 2014$7.55B+34.9%
- 2013$5.60B+7.8%
- 2012$5.19B+14.1%
- 2011$4.55B-12.6%
- 2010$5.21B-10.3%
- 2009$5.81B+9.2%
- 2008$5.32B+28.6%
- 2007$4.13B-0.9%
- 2006$4.17B+3.1%
- 2005$4.04B+71.3%
- 2004$2.36B+6.8%
- 2003$2.21B+39.0%
- 2002$1.59B+53.1%
- 2001$1.04B-13.2%
- 2000$1.20B+55.2%
- 1999$771.10M+21.7%
- 1998$633.70M+23.0%
- 1997$515.10M-7.3%
- 1996$555.70M-9.0%
- 1995$610.50M+52.2%
- 1994$401.10M+79.8%
- 1993$223.10M+205.6%
- 1992$73.00M-28.7%
- 1991$102.40M-299.2%
- 1990−$51.40M+102.4%
- 1989−$25.40M-48.3%
- 1988−$49.10M—
Free Cash Flow values are taken from Amgen's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Amgen (AMGN)
Free Cash Flow for Amgen (AMGN): headline value $8.60B · YoY -22.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Amgen (AMGN) free cash flow totalled $8.10B – declined 22.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Amgen free cash flow compounded at -3.9% per year, with a net decline across the window.
Between 2018 and 2025, Amgen free cash flow declined 23.3%, falling from $10.56B to $8.10B.
Across the available history, free cash flow reached its high of $10.56B in 2018 and its low of −$51.40M in 1990.
Amgen Free Cash Flow by Year
Amgen Free Cash Flow 2025: $8.10B
Amgen free cash flow in 2025 was $8.10B, declined 22.1% below 2024.
Amgen Free Cash Flow 2024: $10.39B
2024's free cash flow for Amgen came in at $10.39B, surged 41.2% from 2023.
Amgen Free Cash Flow 2023: $7.36B
Amgen posted free cash flow of $7.36B in 2023, declined 16.2% below 2022.
Amgen Free Cash Flow 2022: $8.79B
In 2022, Amgen reported free cash flow of $8.79B, edged up 4.8% from 2021.
Amgen Free Cash Flow 2021: $8.38B
Amgen free cash flow in 2021 was $8.38B.
See more financial history for Amgen (AMGN).
Sector peers by Free Cash Flow
Healthcare peers of Amgen (AMGN), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $6.29B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $4.52B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation